Holding(s) in Company
Eco Animal Health Group Plc
For filings with the FCA include the annex | Â | ||||||||||
For filings with issuer exclude the annex | |||||||||||
 | |||||||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||||||||
 |  |  | |||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Eco Animal Health Plc | ||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||||
An acquisition or disposal of voting rights | Â | Â | |||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | ||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | ||||||||||
An event changing the breakdown of voting rights | Â | ||||||||||
Other (please specify): | Â | An amendment to the issued share capital following the Admission of new Ordinary Shares |
X |
||||||||
3. Full name of person(s) subject to the notification obligation: iii |
 | Schroders plc | |||||||||
4. Full name of shareholder(s) (if different from 3.):iv |
 | ||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
23.10.13 | ||||||||||
6. Date on which issuer notified: | 25.10.13 | ||||||||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
19% - 16% |
8. Notified details: | |||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||||||||||||||||||
Class/type of shares
|
 |
Situation previous to the triggering transaction |
 | Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||
Number of Shares |
 |
Number of Voting Rights |
Number of shares |
 |
Number of voting rights |
 | % of voting rights x | ||||||||||||||||||||||||||
 | Direct xi |  | Indirect xii | Direct |  | Indirect | |||||||||||||||||||||||||||
Ordinary
 GB0032036807 |
14,234,808 | 10,849,114 | 12,186,826 | N/A | 10,568,660 | N/A | 16.929% | ||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
 |
Expiration date xiii |
 |
Exercise/ Conversion Period xiv |
 |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
 |
% of voting rights |
|||||||||||||||||||||||||
 |  |  |  |  | |||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
 | Exercise price | Expiration date xvii |  |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | Â | % of voting rights xix, xx | |||||||||||||||||||||||||
 |  |  |  |
 |
Nominal | Â | Delta | ||||||||||||||||||||||||||
 |  | ||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
Total (A+B+C) | |||||||||||||||||||||||||||||||||
Number of voting rights | Â | Percentage of voting rights | |||||||||||||||||||||||||||||||
10,568,660 |
16.929% |
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if applicable: xxi |
|||||
Cazenove Capital Management Limited 16,650 0.027% Â Schroder Investment Management Limited 10,513,541 16.840% Â Schroder & Co Limited 38,469 0.062% |
|||||
 | |||||
Proxy Voting: | |||||
10. Name of the proxy holder: | Â | Â | |||
11. Number of voting rights proxy holder will cease to hold: |
 | ||||
12. Date on which proxy holder will cease to hold voting rights: |
 | ||||
 | |||||
13. Additional information: |
 |
The shares referred to in section 9 are held in portfolios managed
by those firms on a discretionary basis for clients under investment
management agreements.
 This disclosure has been calculated based on issue share capital amount 62,429,321. |
|||
14. Contact name: |
Shaheen Hussain |
||||
15. Contact telephone number: |
020 7658 6000 |